VolitionRx Ltd
VNRX
45 hedge funds and large institutions have $29.3M invested in VolitionRx Ltd in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 5 closing their positions.
9,200% more call options, than puts
Call options by funds: $93K | Put options by funds: $1K
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
34% more capital invested
Capital invested by funds: $22M → $29.3M (+$7.39M)
0.07% more ownership
Funds ownership: 0.71% → 0.78% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 47 → 45 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$600K |
| 2 |
Morgan Stanley
New York
|
+$507K |
| 3 |
State Street
Boston,
Massachusetts
|
+$390K |
| 4 |
BlackRock
New York
|
+$335K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$193K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCM
Ovata Capital Management
Hong Kong
|
-$164K |
| 2 |
Goldman Sachs
New York
|
-$159K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$65.7K |
| 4 |
OC
Oppenheimer & Co
New York
|
-$60K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$60K |
VNRX Hedge Fund Activity: Q4 2020 in Review
45 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2020, worth a combined $29.3M — up 34% from $22M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VNRX and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 22 added.
The largest buyer was Lagoda Investment Management, adding an estimated $600K. The largest seller was Ovata Capital Management, cutting an estimated $164K.
- 45 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2020, down from 47 in Q3 2020.
- Funds reported $29.3M of VolitionRx Ltd stock for Q4 2020, up 34% quarter-over-quarter.
- 3 funds opened new VolitionRx Ltd positions in Q4 2020 and 5 closed out, a net change of -2 holders.
- The largest VolitionRx Ltd buyer in Q4 2020 was Lagoda Investment Management, an estimated $600K added.
- The largest VolitionRx Ltd seller in Q4 2020 was Ovata Capital Management, an estimated $164K sold.
Based on aggregated 13F filings for Q4 2020.